By Puyaan Singh and Padmanabhan Ananthan July 16 (Reuters) - The U.S. FDA approved Merck's cholesterol-lowering pill, it said ...

The U.S. Food and Drug Administration has approved Merck's Lipfendra (enlicitide), making it the first oral PCSK9 inhibitor ...

A study has determined that adverse effects leading to treatment discontinuation vary among different blood pressure-lowering drug classes.

Lipfendra (enlicitide) offers a convenient option for adults who haven’t been able to lower their cholesterol sufficiently with statins. The U.S. Food and Drug Administration (FDA) approved Lipfendra ...

Common medications that make summer heat dangerous for seniors They did everything right. They kept the windows open. They ...

Ever bought a new type of soda and realized it was an herbal “mood” drink or “social tonic?” They’re sold next to soft drinks, but these drinks contain herbal supplements, some of which can interact ...

A snack recall first issued in the spring now carries the federal government’s most serious warning level.The US Food and ...

LUCENA CITY – Four suspected drug traffickers were arrested in separate anti-narcotics operations in Quezon province on ...

The approval of Lipfendra gives Merck the first oral PCSK9 cholesterol-lowering drug in the US market, strengthening its ...

The FDA is reviewing which compounded peptides will be permitted for production by specialized pharmacies, threatening consumer access.

China on Thursday released an updated national essential medicines list, expanding it from 685 to 794 items to better meet ...

Amgen recalled nearly one million bottles of Corlanor and Sensipar tablets after unexpected foreign matter was found on tablet surfaces during sampling.